Essentials of Quality Control

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Advertisements

CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
Chicken Soup for the Busy Coordinator
Managing Regulatory Documents Electronically
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
A Blueprint For Clinical Research: Standard Operating Procedures
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Monitoring and Auditing
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Fundamentals of ICH and GCP
6/1/09.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Common Audit Findings UTHSC Institutional Review Board (IRB)
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Read the SMALL PRINT of the 1572 The Essential GCP Document.
Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
Remote Site Initiation Visits
Essentials of Quality Control
Workforce Development Domain Task Force
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
The Role and Responsibilities of the Clinical Research Coordinator
Tips on How to Increase Screening and Enrollment into Clinical Trials
Responsibilities of Sponsor, Investigator and Monitor
Reportable Events Emory IRB 9/11/2014.
OUS Data: What does the CE Mark Really Mean?
MAINTAINING THE INVESTIGATOR’S SITE FILE
Investigator of Record – Definition
How to Handle FDA Audits
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Alyssa Speier, MS, CIP November 13, 2013
The Art of Consenting: Tips to Meeting Enrollment Goals
Bozeman Health Clinical Research
CLINICAL DATA MANAGEMENT
Remote Monitoring of Protocol Deviations
Findings Noted During Audits and How to Correct Them
Regulatory Binder: Maintaining Essential Study Documentation
Top Ten eIRB Application Mistakes
Elements of an Organized Regulatory Binder
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Investigator of Record – Definition
Investigator of Record – Definition
Consent Training Module
Cindy Murray NP Princess Margaret Cancer Centre
Quality Assurance in Clinical Trials
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Good clinical practice
Presentation transcript:

Essentials of Quality Control D. Chris Metzger, MD, FACC, FSCAI Wellmont CVA Heart Institute Kingsport, TN, USA

D. Christopher Metzger, MD Consulting: Abbott, Cordis, IDEV, Medtronic Hands- On PV and CAS Courses: Abbott, Medtronic National Co-PI: SAPPHIRE WW CAS (Cordis) CEC Committee: Covidien(DEFINITIVE) National PI: CANOPY

Why Quality Control? Good research results come only from quality work It is easy for quality to be less than you assume without quality checks Your site’s reputation (& future invitations) depend on quality work FDA audits come without significant advanced notice

Principal Investigators Pay Attention, because….

Primary Investigators.. PI is Ultimately responsible for the conduct of ALL aspects of the study (no matter who makes the mistake) Essential to take “hands on” approach- take personal responsibility for conduct of your study Educate/train/monitor sub-I’s, RC’s,etc. Meet personally w/ study monitors Learn from mistakes, modify approach

The Best Way to Handle Research Mistakes is to Avoid Them

Ways to Avoid Mistakes Make sure all investigators & RC’s know protocol AND follow it Create enrollment Inc/Exc. List AND Worksheet with all studies/info that will be needed for data entry Have 2 team members confirm I/E & Informed Consent “Reconfirm” consent (ex: day after AMI) Follow Research pt’s until hospital DC, give appt card Have protocol available AND RC present (as possible) for all procedures DOCUMENT, re-document, BE Careful with good Informed Consent (FDA focus!); Keep the ORIGINAL ICF

Avoiding AND Discovering Deviations PI, Research Manager, and Lead RC for study should meet with study monitor! Regular Research Mtgs (monthly) with Investigators and entire Research team Have representative @ all IRB Meetings Have an FDA audit! Treat every study like it will have an FDA audit

Study Monitors They are your allies! They provide quality control & help prepare for FDA Do not be defensive with them Have lead RC prepare for each visit Meet personally with them Review their letter & respond in writing Generate a “to do list” based on their visit/ letter, and sign off on each task

Lead Research Coordinator We have a “Lead RC” for every study Responsible for ensuring data gathered from hospital/procedure, scheduling F/U, seeing F/U pt’s, preparing for monitors, resolving queries,… “Theirs!” Generates worksheets for study Meets w/ PI & Research Mgr. regularly

Mistakes/ Deviations- Now What? Do a timely, meaningful Note to File NTF should include corrective action which is implemented. This is track-able Learn from mistakes- share @ Res. Mtgs. Document & File NTF and corrective plans Report mistakes, AE’s, SAE’s to sponsor and IRB asap (even if late) Meet w noncompliant investigators and RC’s

Other Tips for Maintaining Quality Have all research members undergo Good Clinical Practice training- Docs too! The more training & interaction the better- research meetings, GCP, investigator/RC mtgs, Scientific Mtgs, NIH training, etc. Document this Research Team interactive meetings Use outside Consultants prn for training and site review

CONCLUSIONS Quality research depends on quality work and quality control PI’s should be hand-on leaders Quality control must be an on-going process, and is facilitated by meeting with monitors, regular research team interaction, prospective worksheet approach, trained personnel, and timely corrective action when problems arise.

Thank You for Your Attention!